The CNAT chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the CNAT chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.
The CNAT stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.
|View CNAT Detailed Price Forecast - CNN Money||View CNAT Detailed Summary - Google Finance|
|View CNAT Detailed Summary - Yahoo! Finance||View CNAT Stock Research & Analysis - Zacks.com|
|View CNAT Trends & Analysis - Trade-Ideas||View CNAT Major Holders - Barrons|
|View CNAT Call Transcripts - NASDAQ||View CNAT Breaking News & Analysis - Seeking Alpha|
|View CNAT Annual Report - CompanySpotlight.com||View CNAT OTC Short Report - OTCShortReport.com|
|View CNAT Fundamentals - TradeKing||View CNAT SEC Filings - Bar Chart|
|View Historical Prices for CNAT - The WSJ||View Performance/Total Return for CNAT - Morningstar|
|View the Analyst Estimates for CNAT - MarketWatch||View the Earnings History for CNAT - CNBC|
|View the CNAT Earnings - StockMarketWatch||View CNAT Buy or Sell Recommendations - MacroAxis|
|View the CNAT Bullish Patterns - American Bulls||View CNAT Short Pain Metrics - ShortPainBot.com|
|View CNAT Stock Mentions - StockTwits||View CNAT Stock Mentions - PennyStockTweets|
|View CNAT Stock Mentions - Twitter||View CNAT Investment Forum News - Investor Hub|
|View CNAT Stock Mentions - Yahoo! Message Board||View CNAT Stock Mentions - Seeking Alpha|
|View Insider Transactions for CNAT - SECform4.com||View Insider Transactions for CNAT - Insider Cow|
|View CNAT Major Holdings Summary - CNBC||View Insider Disclosure for CNAT - OTC Markets|
|View Insider Transactions for CNAT - Yahoo! Finance||View Institutional Holdings for CNAT - NASDAQ|
|View CNAT Stock Insight & Charts - FinViz.com||View CNAT Investment Charts - StockCharts.com|
|View CNAT Stock Overview & Charts - BarChart||View CNAT User Generated Charts - Trading View|
Edited Transcript of CNAT earnings conference call or presentation 8-Mar-19 9:30pm GMT
Posted on Thursday March 14, 2019
Q4 2018 Conatus Pharmaceuticals Inc Earnings Call
Implied Volatility Surging for Conatus (CNAT) Stock Options
Posted on Wednesday March 13, 2019
Conatus (CNAT) needs investors to pay close attention to the stock based on moves in the options market lately.
Conatus Late-breaker Oral Presentation at EASL Meeting to Detail Results of ENCORE-PH Phase 2b Clinical Trial in Patients with NASH Cirrhosis and Severe Portal Hypertension
Posted on Wednesday March 13, 2019
The oral presentation at EASL entitled, “Multicenter, Double-blind, Placebo-controlled, Randomized Trial of Emricasan in Subjects with NASH Cirrhosis and Severe Portal Hypertension (PH),” (#LB01) will detail results from the company’s Phase 2b ENCORE-PH clinical trial of emricasan, the company’s first-in-class, orally active pan-caspase protease inhibitor. Guadalupe Garcia-Tsao, M.D., Professor of Medicine in the Section of Digestive Diseases at Yale School of Medicine, Director of the Clinical and Translational Core at Yale Liver Center, Chief of the Section of Digestive Diseases at the Veterans Administration-Connecticut Health Care System, and the central reader in the ENCORE-PH trial, will deliver the presentation on Saturday, April 13, at 4:00 p.m. CEST.
Conatus' (CNAT) Q4 Earnings Top Estimates, Emricasan in Focus
Posted on Monday March 11, 2019
Conatus (CNAT) makes an improvement with narrower-than-expected loss in the fourth quarter of 2018. Also, revenues beat mark.